Navigation Links
Alexza Presents Staccato® Loxapine Responder Analyses in Agitated Adult Patients with Schizophrenia or Bipolar Disease at the 2011 USPMHC Annual Conference
Date:11/8/2011

-I responders, compared with 27.6% of placebo patients.  In both patient populations, the CGI-I responders were statistically significantly greater for patients treated with either dose of Staccato loxapine, compared to patients who received Staccato placebo.  The results for the CGI-I Responders analysis are summarized below.

Staccato Loxapine CGI-I Responder Analysis2-Hour CGI-Improvement(% of Patients Rated as "Much Improved" or "Very Much Improved")Schizophrenia

Bipolar DisorderStaccato Loxapine Dose Group

Patients

Patients10mg

67%

74%5mg

57%

66%Placebo

36%

28%About Alexza Pharmaceuticals, Inc.

Alexza is a pharmaceutical company focused on the research, development and commercialization of novel, proprietary products for the acute treatment of central nervous system conditions.  Alexza's technology, the Staccato® system, vaporizes unformulated drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery through deep lung inhalation.  The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. (Click here to see an animation of how the Staccato system works.)

ADASUVE™ (Staccato loxapine) is Alexza's lead program, which is being developed for the acute treatment of agitation in adults with schizophrenia or bipolar disorder.  Alexza completed and announced positive results from both of its Phase 3 clinical trials and initially submitted the ADASUVE NDA in December 2009.  In October 2010, the Company received a Complete Response Letter from the FDA regarding the application.  The Company completed an end-of-review meeting w
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... PLYMOUTH MEETING, Pa. , Dec. 15, 2014 ... ) announced today it has been added to ... the NASDAQ Biotechnology Index will become effective upon ... The NASDAQ Biotechnology Index is designed to track ... that are classified as either biotechnology or pharmaceutical ...
(Date:12/15/2014)... 2014  Stephen Squires, CEO and founder of leading ... (OTCQB:QTMM), will be speaking at the launch event ... December 16th, 2014. The RCQM launch continues Rice University,s ... top faculty and students and by inviting the world,s ... "We have a long association with Rice ...
(Date:12/13/2014)... , Dec. 11, 2014 Research and ... the addition of the "Drug Injection Devices ... http://photos.prnewswire.com/prnh/20130307/600769 ... of an expanding list of health conditions, drug ... that simplify the administration process and increase the ...
Breaking Medicine Technology:Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 2Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 3Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 4Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 2Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 3Drug Injection Devices to 2020 2Drug Injection Devices to 2020 3Drug Injection Devices to 2020 4
... March 1, 2011 Syndax Pharmaceuticals, a clinical-stage ... (NCI) will sponsor a multi-center phase 2 study ... of histone deacetylases (HDAC), and anastrozole, an aromatase ... breast cancer to evaluate biomarkers and surrogates for ...
... Conn., March 1, 2011 To kick off ... products and the Colon Cancer Alliance (CCA) have teamed ... the fears of the colonoscopy. Colon cancer is 90 percent ... avoid getting a colonoscopy—the colon cancer screening test that could ...
Cached Medicine Technology:Syndax Announces Start of NCI Sponsored Phase 2 Study of Entinostat in Combination in Triple Negative Breast Cancer 2Syndax Announces Start of NCI Sponsored Phase 2 Study of Entinostat in Combination in Triple Negative Breast Cancer 3Syndax Announces Start of NCI Sponsored Phase 2 Study of Entinostat in Combination in Triple Negative Breast Cancer 4Carmen Marc Valvo, Designer and Cancer Survivor, Teams Up With Dulcolax® and the Colon Cancer Alliance to Make it Fashionable for Americans to Get Screened 2Carmen Marc Valvo, Designer and Cancer Survivor, Teams Up With Dulcolax® and the Colon Cancer Alliance to Make it Fashionable for Americans to Get Screened 3Carmen Marc Valvo, Designer and Cancer Survivor, Teams Up With Dulcolax® and the Colon Cancer Alliance to Make it Fashionable for Americans to Get Screened 4Carmen Marc Valvo, Designer and Cancer Survivor, Teams Up With Dulcolax® and the Colon Cancer Alliance to Make it Fashionable for Americans to Get Screened 5
(Date:12/17/2014)... (PRWEB) December 17, 2014 Unidesk ... Osteopathic Medicine (ACOM), which welcomed its inaugural class ... Infrastructure (VDI) to seamlessly support bring your own ... and teaching – experience. The solution, comprised of ... , Dell server and storage infrastructure ...
(Date:12/17/2014)... No matter how far modern medicine advances, ... head louse parasite—a common childhood malady and a source ... six and twelve million individuals will suffer an infestation. ... company comes to the rescue, providing an all-natural treatment ... track record of customer service, and effectiveness in getting ...
(Date:12/17/2014)... News) -- Expectant parents should leave prenatal picture-taking to ... Use of ultrasound imaging and heartbeat monitors to ... the agency warns. "Although there is a ... imaging and heartbeat monitors, prudent use of these devices ... an FDA biomedical engineer, said in an agency news ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, 2014 ... and work commitment is a big reason why, new research ... Dr. Mathias Basner, an assistant professor of sleep and chronobiology ... Medicine. A time-use survey of nearly 125,000 Americans, ages ... activity exchanged for sleep. Short sleepers -- those who slept ...
(Date:12/15/2014)... (PRWEB) December 15, 2014 South Florida’s leading ... that holidays can be a daze of hassle, hustle, and ... falls while decking halls, to burns when making special meals ... hazards that can happen at any time. To prevent this ... Now has made a list of helpful and healthful holiday ...
Breaking Medicine News(10 mins):Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 2Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 3Health News:Lice Troopers Announces New Lice Treatment Clinic in Coral Gables to Service Key Biscayne, Coconut Grove, Kendall, Brickell & South Miami 2Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3
... ... chooses proven business veteran to lead charge into burgeoning solar tracker market. , ... Roseville, CA (PRWEB) January 28, 2009 -- ... industry, is pleased to announce that James E. Green has accepted the role of Chief ...
... Doctors urged to follow up on testing for suspected developmental ... U.S. pediatricians are doing a good job of screening children ... testing or treatment, researchers say. , "The ultimate goal ... delays, but in our study we found that many pediatricians ...
... ... affiliated ambulatory practices ,gain access to single source provider. , ... Dallas, TX (Vocus) January ... (EHR) and practice management (PM) systems for medical practices, today announced that Massachusetts-based ...
... , , HARRISBURG, Pa. , ... largest dental insurers, will observe February as National Children,s Dental Health ... serves through education and sponsorship of at least 70 free dental ... is the most common disease in America, affecting people of all ...
... , , TROY, Mich. ... ) an information technology (IT) and web products and services ... Mercy Memorial Hospital System of Monroe, Michigan ( ... designed to control, coordinate and automate all service requests at ...
... of the mothers who took part in a study thought that ... 39 per cent of the fathers, according to the February issue ... overweight children, 75 per cent of mothers and 77 per cent ... than 800 parents of 439 children took part in the study, ...
Cached Medicine News:Health News:Inspired Solar Technologies (IST) Names James E. Green as CEO 2Health News:Kids' Screenings in Place, But Referrals Lacking 2Health News:Aprima and Iatric Systems Partnership Brings Electronic Health Record and Practice Management Solution to MEDITECH Providers 2Health News:United Concordia Dental Honors February as National Children's Dental Health Month 2Health News:Mercy Memorial Hospital Selects CareTech Solutions to Provide Service Desk Support to Physicians, Nurses, and Hospital Personnel 2Health News:Mercy Memorial Hospital Selects CareTech Solutions to Provide Service Desk Support to Physicians, Nurses, and Hospital Personnel 3Health News:Most parents don't realize their 4 or 5 year-olds are overweight or obese 2
... Tip Ureteral Stents combine a unique polymer ... remembering its shape with a chemically bonded ... The result is a stent that satisfies ... patient comfort. Lubri-Flex® is available in a ...
All the advantages of Dr. Roy P. Finney's classic stent design with an open tip....
... ambulatory ECG technology - Until now, if ... Holter on some of your patients while ... the majority of patients, you had to ... Now, all that has changed with Lifecard ...
The Pathfinder HSV 1 and 2 kit provides direct antigen detection and differentiation of Herpes Simplex Virus (HSV) Types 1 and 2. The monoclonal antibody-based test can be used to directly stain cli...
Medicine Products: